Drawing for CLINOPS

USPTO serial 77631348

CLINOPS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HELFMAN, JUDITH MICHELLE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLINOPS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carol H. Peters

CAROL H. PETERS MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO, P.C.ONE FINANCIAL CENTERBOSTON, MA 02111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Clinical site and operations management services for drug, medical device, and diagnostic test and device development studies, projects, and clinical trials conducted by pharmaceutical, biotechnology, diagnostics, and medical device companies and manufacturers; statistical analysis and reporting services in the areas of drug, medical device, and diagnostic test and device development and clinical trials conducted by pharmaceutical, biotechnology, diagnostics, and medical device companies and manufacturers; providing data management and compilation services for reporting purposes, namely, compiling, managing and analyzing information and data produced from drug, medical device, and diagnostic test and device development studies and clinical trials; assisting others with preparing applications and submissions to the Food and Drug Administration and other regulatory authoritiesACTIVE—
042Computer software consulting and development services, namely, computer software consulting and development, computer software programming, and SAS programming in the areas of pharmaceutical, medical device, and diagnostic test and device development and clinical trials conducted by pharmaceutical, biotechnology, diagnostics, and medical device companies and manufacturers; and technical writing for pharmaceutical, biotechnology, diagnostics, and medical device companies and manufacturers; database design and development, namely, creating databases from scientific and clinical protocols for drug, medical device, and diagnostic test and device development studies and clinical trials, and creating databases from data produced by drug, medical device, and diagnostic test and device development studies and clinical trials; compiling and analyzing information and data produced from drug, medical device, and diagnostic test and device development studies and clinical trials for research consultancy purposeACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 19, 2011MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 19, 2011ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 18, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 17, 2011EX2GSOU EXTENSION 2 GRANTED—
Feb 16, 2011EXT2SOU EXTENSION 2 FILED—
Feb 16, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 22, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 21, 2010EX1GSOU EXTENSION 1 GRANTED—
Sep 21, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 18, 2010TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Aug 18, 2010PETGPETITION TO REVIVE-GRANTED—
Aug 18, 2010PROATEAS PETITION TO REVIVE RECEIVED—
Aug 16, 2010EXT1SOU EXTENSION 1 FILED—
Feb 18, 2010ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 16, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 24, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 24, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 20, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Oct 20, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 20, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 20, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 7, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 7, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 7, 2009PETGPETITION TO REVIVE-GRANTED—
Oct 7, 2009PROATEAS PETITION TO REVIVE RECEIVED—
May 12, 2009DOCKASSIGNED TO EXAMINER—
Mar 30, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2009AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 14, 2009ALIEASSIGNED TO LIE—
Mar 12, 2009PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 9, 2009DOCKASSIGNED TO EXAMINER—
Dec 16, 2008MPMKNOTICE OF PSEUDO MARK MAILED—
Dec 15, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance